CN105456737A - Preparation method and preparation of traditional Chinese medicinal composition for treating gastritis - Google Patents

Preparation method and preparation of traditional Chinese medicinal composition for treating gastritis Download PDF

Info

Publication number
CN105456737A
CN105456737A CN201510939830.5A CN201510939830A CN105456737A CN 105456737 A CN105456737 A CN 105456737A CN 201510939830 A CN201510939830 A CN 201510939830A CN 105456737 A CN105456737 A CN 105456737A
Authority
CN
China
Prior art keywords
preparation
extractum
concentrated
chinese medicine
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201510939830.5A
Other languages
Chinese (zh)
Inventor
陈致慜
马靖喧
李春雷
霍志金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HANDAN PHARMACEUTICAL CO Ltd
Original Assignee
HANDAN PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HANDAN PHARMACEUTICAL CO Ltd filed Critical HANDAN PHARMACEUTICAL CO Ltd
Priority to CN201510939830.5A priority Critical patent/CN105456737A/en
Publication of CN105456737A publication Critical patent/CN105456737A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8967—Lilium, e.g. tiger lily or Easter lily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739—Sanguisorba (burnet)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/808—Scrophularia (figwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/884—Alismataceae (Water-plantain family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968—Ophiopogon (Lilyturf)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8984—Dendrobium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a preparation method of a traditional Chinese medicinal composition, in particular to a preparation method of a traditional Chinese medicinal composition for treating gastritis and a pharmaceutical preparation prepared by the method. A product prepared by the method of the invention has the characteristics of good stability, significant therapeutic effect and the like. The preparation method comprises the following steps: crushing the following six medicines into powder: bulbs lili, panax notoginseng, endothelium corneum gigeriae galli, pollen typhae, rhizoma corydalis and rhizoma anemones altaicae; decocting rest medicines in water, combining medicine liquids, filtering and concentrating so as to obtain an extract; performing heat reflux extraction on medicine dregs obtained from decoction with the addition of ethanol, combining medicine liquids and filtering, recovering ethanol and concentrating so as to obtain an extract; and mixing the powder with the two extracts so as to obtain medicine active substances, and preparing the active substances into the pharmaceutical preparation composition by virtue of a pharmaceutical method.

Description

A kind of Chinese medicine composition preparation method and preparation for the treatment of gastritis
Invention field
The present invention relates to a kind of preparation method of Chinese medicine composition, the preparation method being particularly used for the treatment of the Chinese medicine composition of gastritis and the pharmaceutical preparation prepared by the method.
Background technology
MOLUO DAN is a kind of regulating the stomach and sending down the abnormal ascending QI, spleen invigorating relieving distension, the medicine of dredging collateral to stop pain.For chronic atrophic gastritis and have a stomach-ache, distension, painful abdominal mass is vexed, indigestion and loss of appetite, belch, the heartburn disease that Dengs.Usage and dosage, oral, honeyed pill 9 ~ 18g, 3 times on the one, ante cibum rice water or warm water send down, or to follow the doctor's advice.It is formed by the 18 taste Chinese drug preparations such as Bulbus Lilii, Radix Ophiopogonis, Herba Dendrobii, Poria, the Rhizoma Atractylodis Macrocephalae (parched with bran), the Radix Linderae, the Radix Paeoniae Alba, Radix Notoginseng, Rhizoma Corydalis (processed with vinegar), Endothelium Corneum Gigeriae Galli (frying fragrant), Radix Scrophulariae, Radix Angelicae Sinensis, and pharmacological action is as follows
1 effect: Radix Angelicae Sinensis all has inhibitory action to dysentery bacterium, vibrio cholera, Bacillus proteus, escherichia coli, and Radix Notoginseng total arasaponins has comparatively high inhibition effect to some fungus.
2 gastric mucosas: we have repair to gastric mucosa injury.
The 3 reason research Radixs Linderae have dual regulation that is excited and that suppress to gastrointestinal smooth muscle, and facilitating digestion liquid is secreted; Endothelium Corneum Gigeriae Galli improves gastric secretion, acidity and digestion power.
4 immunologic functions: according to pharmacological experiment Poria, the Rhizoma Atractylodis Macrocephalae except spleen invigorating, effectively improve humoral immune function.
5 pharmacology find that in we, Radix Notoginseng, Radix Angelicae Sinensis, Poria etc. all have hepatoprotective, relieving alcohol liver poisoning, promote the function of seroconversion in liver.
Chinese patent discloses the following formula of MOLUO DAN preparation
Described Rhizoma Atractylodis Macrocephalae parched with bran, Rhizoma Corydalis processed with vinegar, Endothelium Corneum Gigeriae Galli (parched) selected by Endothelium Corneum Gigeriae Galli.
And preparation method:
Above 18 tastes, decoct with water 1-3 time, each 1.5-3 hour, collecting decoction, filter, filtrate is concentrated in right amount, add ethanol, make alcohol content reach 60-80%, leave standstill, filter, reclaim ethanol, filtrate concentrates, and add water cold preservation, filter, eventually pass normal process steps directly or add pharmaceutically acceptable excipient and make clinical acceptable dosage form.
Chinese patent 200710120838.4 discloses the following content assaying method of MOLUO DAN,
Assay is as follows:
According to high effective liquid chromatography for measuring;
Chromatographic condition and system suitability test: be filler with octadecylsilane chemically bonded silica; With the acetonitrile-water of 15-60:40-85 for mobile phase; Determined wavelength is 230nm, and number of theoretical plate calculates should be not less than 1000 ~ 5000 by peoniflorin peak;
The preparation of reference substance solution: it is appropriate that precision takes peoniflorin reference substance, solubilizer methanol, ethanol, n-butyl alcohol, water, chloroform or ethyl acetate make the solution of every 1ml containing 30-50 μ g, to obtain final product;
The preparation of need testing solution: get the big honeyed pills under MOLUO DAN small honey pill or weight differential item, shred, precision takes 1 ~ 10g, add kieselguhr 1 ~ 10g, grind well, put in tool plug conical flask, precision adds solvent methanol, ethanol, n-butyl alcohol, water, chloroform or ethyl acetate 15-25ml, close plug, weigh, supersound process or hot reflux or merceration extract 30 minutes, taking-up is put and is weighed to room temperature, with solvent methanol, ethanol, n-butyl alcohol, water, chloroform or ethyl acetate complement to 15-25ml and shake up, filter, accurate absorption subsequent filtrate 4-6ml, put in 10ml measuring bottle, solubilizer methanol, ethanol, n-butyl alcohol, water, chloroform or diluted ethyl acetate are to scale, shake up, obtain,
Algoscopy: accurate absorption reference substance solution and each 20 μ l of need testing solution respectively, injection liquid chromatography, measures, to obtain final product; The every 1g of MOLUO DAN contains the Radix Paeoniae Alba with peoniflorin C 23h 28o 11meter, must not be less than 0.8mg.
The present inventor finds in clinical and production practices, prior art is in curative effect, stability, the aspects such as the saving of raw material need to improve, and to improve the effect of medicine, extend shelf life, reduce the use amount of medicine, improve the adaptability of medicine, the present inventor improves prior art for this reason, thus completes the present invention.
Summary of the invention:
For improving the defect of prior art, the invention provides a kind of new preparation method of MOLUO DAN, the method for the invention, its formula is as follows:
Its preparation method is as follows:
Bulbus Lilii, Radix Notoginseng, Endothelium Corneum Gigeriae Galli, Pollen Typhae, Rhizoma Corydalis, Rhizoma Anemones Altaicae Six-element medicated powder are broken into 80-200 order powder; Residue flavour of a drug decoct with water 2-4 time, each 0.5-3 hour, merge medicinal liquid and filter the extractum being concentrated into relative density 1.10-1.50; The alcohol heat reflux that medicinal residues after decoction add 30-80% extracts 1-2 time, each 0.5-2 hour, merges medicinal liquid and filters, reclaim ethanol, be concentrated into the extractum of relative density 1.10-1.50; Powder mixes with 2 kinds of extractum, obtains pharmaceutically active substance, through formulation method, is prepared into pharmaceutical preparations composition.
Preferably, preparation method of the present invention is as follows:
Bulbus Lilii, Radix Notoginseng, Endothelium Corneum Gigeriae Galli, Pollen Typhae, Rhizoma Corydalis, Rhizoma Anemones Altaicae Six-element medicated powder are broken into 80-200 order powder; Residue flavour of a drug decoct with water 3 times, each 2 hours, merge medicinal liquid and filter the extractum being concentrated into relative density 1.10-1.50; The alcohol heat reflux that medicinal residues after decoction add 55% extracts 2 times, each 1 hour, merges medicinal liquid and filters, reclaim ethanol, be concentrated into the extractum of relative density 1.10-1.50; Powder mixes with 2 kinds of extractum, is mixed to get pharmaceutically active substance, through formulation method, is prepared into pharmaceutical preparations composition.
The preferred preparation of the present invention is concentrated pill, and its preparation method is as follows, get active constituents of medicine that powder mixes with extractum, pulverize after every 1 weight portion of medicated powder add 0.6-1.5 weight portion refined honey and make concentrated honeyed pill.
Compared to the prior art, main active obviously increases method of the present invention, and drug effect significantly improves, and preparation stability significantly improves,
Below by way of experimental data, beneficial effect of the present invention is described:
Experiment content:
The present invention and prior art carry out contrast experiment
Test 1, acidic ethanol caused to the impact of rat acute mucosal lesion
Animal grouping administration, in administration the 7th day each treated animal respectively fasting can't help water 48h, each treated animal gastric infusion (water) 1 time again before test, every rat oral gavage acidic ethanol 2ml (150mmol/L hydrochloric acid mixes in 1: 1 ratio with 60% ethanol) after 2h, use excess diethyl ether anesthetized rat lethal after 1h respectively, open abdomen and get stomach, use clamp cardia, 1% formalin 5ml is injected by pylorus, clamping pylorus, full stomach is placed in 1% formalin and fixes 10min, cut off along greater gastric curvature, stomach is turned up, content is washed away gently with clear water, stomach is laid on glass plate, mucosal lesion length is measured with precimeter, using damaged length (damage width is greater than 1mm person to be doubled to calculate) summation as gastric mucosal damage index, and calculate suppression ratio.
Experimental result is as follows:
From result, each group gastric mucosa all has and damages in various degree, and all comparatively model control group is light for of the present invention group and prior art group, and damage index obviously reduces (P<0.05).
The comparison of rat regenerated mucosa thickness
Group Number of animals (only) Regenerated mucosa thickness (μm)
Matched group 10 400
Model group 10 100
Of the present invention group 10 325
Prior art group 10 280
The comparison of ulcer stove granulation cicatrix layer thickness
Group Number of animals (only) Granulation cicatrix layer thickness (μm)
Matched group 10 0
Model group 10 0.58
Of the present invention group 10 0.14
Prior art group 10 0.22
Experiment 2, impact on rat gastric secretion
Animal grouping administration, often organize 10 rats, each treated animal fasting taboo water 24h respectively after last administration, with etherization, osculum is cut off along ventrimeson, pull out stomach gently, ligation pylorus, again by duodenal administration 1 time, suturing them otch, fu jie of taking out stitches out after 6h pricks cardia, extract full stomach, bloodstain is cleaned with filter paper, coat of the stomach is cut off along greater gastric curvature, incline and gastric content, be collected in graduated centrifuge tube, with 1500r/min centrifugation 10min, accurate record gastric juice amount, be that indicator measures total acidity gastric juice with phenol red, the special capillary tube method of wheat is adopted to measure pepsin activity.
Experimental result is as follows:
From result, of the present invention group and prior art group all can reduce total acidity gastric juice and pepsin activity.
Antibacterial tests in experiment 3, body:
Of the present invention group and prior art group all can reduce infection of staphylococcus aureus dead mouse number, extend the survival natural law of infecting mouse;
Experimental result is as follows:
Group Number of animals (only) Death toll (only) Survival rate %
Normal group 20 0 100
Model group 20 12 40
Of the present invention group 20 6 70
Prior art group 20 8 60
Test 4. anti-inflammation test results:
Of the present invention group and prior art group all can reduce dimethylbenzene induced mice auricle swelling degree.
On mice delayed allergy (the sufficient sole of the foot thickens method) impact (sufficient sole of the foot thickness difference mm)
Dosage group Number of animals (only) 24h swelling degree of the paw (mm) after injection
Negative control group 10 0.213
Of the present invention group 10 0.464
Prior art group 10 0.344
Experiment 5, accelerated stability experiment
Sample is placed on 40 DEG C ± 2 DEG C, is positioned in climatic chamber under the condition of relative humidity 75% ± 5%, with setting-up time sampling, carry out assay to related component, the primary stability result of the test after test is as follows
Primary stability result of the test after inventive samples test
Primary stability result of the test after prior art sampling test
Advantage of the present invention is mainly manifested in:
By improving preparation method, achieve following technique effect: the dose reducing medicine, the content of active component increases, and preparation stability increases, and the curative effect of medicine increases.Detailed description of the invention:
Further illustrate the present invention by the following examples, but not as limitation of the present invention.
Embodiment 1
Its preparation method is as follows:
Bulbus Lilii, Radix Notoginseng, Endothelium Corneum Gigeriae Galli, Pollen Typhae, Rhizoma Corydalis, Rhizoma Anemones Altaicae Six-element medicated powder are broken into 80-200 order powder; Residue flavour of a drug decoct with water 3 times, each 2 hours, merge medicinal liquid and filter the extractum being concentrated into relative density 1.10-1.50; The alcohol heat reflux that medicinal residues after decoction add 55% extracts 2 times, each 1 hour, merges medicinal liquid and filters, reclaim ethanol, be concentrated into the extractum of relative density 1.10-1.50; Powder mixes with 2 kinds of extractum, obtains pharmaceutically active substance, and pill, drying make concentrated pill; Or powder mixes with extractum, granulates, capsule is made in drying or tablet;
Embodiment 2
Its preparation method is as follows:
Bulbus Lilii, Radix Notoginseng, Endothelium Corneum Gigeriae Galli, Pollen Typhae, Rhizoma Corydalis, Rhizoma Anemones Altaicae Six-element medicated powder are broken into 80 order powder; Residue flavour of a drug decoct with water 2 times, each 0.5 hour, merge medicinal liquid and filter the extractum being concentrated into relative density 1.10-1.50; The alcohol heat reflux that medicinal residues after decoction add 30% extracts 1 time, each 0.5 hour, merges medicinal liquid and filters, reclaim ethanol, be concentrated into the extractum of relative density 1.10-1.50; Powder mixes with 2 kinds of extractum, obtains pharmaceutically active substance, and pill, drying make concentrated pill; Or powder mixes with extractum, granulates, capsule is made in drying or tablet;
Embodiment 3
Its preparation method is as follows:
Bulbus Lilii, Radix Notoginseng, Endothelium Corneum Gigeriae Galli, Pollen Typhae, Rhizoma Corydalis, Rhizoma Anemones Altaicae Six-element medicated powder are broken into 200 order powder; Residue flavour of a drug decoct with water 4 times, each 3 hours, merge medicinal liquid and filter the extractum being concentrated into relative density 1.10-1.50; The alcohol heat reflux that medicinal residues after decoction add 80% extracts 2 times, each 2 hours, merges medicinal liquid and filters, reclaim ethanol, be concentrated into the extractum of relative density 1.10-1.50; Powder mixes with 2 kinds of extractum, obtains pharmaceutically active substance, and pill, drying make concentrated pill; Or powder mixes with extractum, granulates, capsule is made in drying or tablet;
Sample prepared by above embodiment method, measures through determination: every 1g contains the Radix Paeoniae Alba with peoniflorin C 23h 28o 11meter, is no less than 1.4mg.

Claims (8)

1. treat a preparation method for the Chinese medicine composition of gastritis, described Chinese medicine composition is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
It is characterized in that, described preparation method step is as follows:
Bulbus Lilii, Radix Notoginseng, Endothelium Corneum Gigeriae Galli, Pollen Typhae, Rhizoma Corydalis, Rhizoma Anemones Altaicae Six-element medicated powder are broken into 80-200 order powder; Residue flavour of a drug decoct with water 2-4 time, each 0.5-3 hour, merge medicinal liquid and filter the extractum being concentrated into relative density 1.10-1.50; The alcohol heat reflux that medicinal residues after decoction add 30-80% extracts 1-2 time, each 0.5-2 hour, merges medicinal liquid and filters, reclaim ethanol, be concentrated into the extractum of relative density 1.10-1.50; Powder mixes with 2 kinds of extractum, obtains pharmaceutically active substance, through formulation method, is prepared into pharmaceutical preparations composition.
2. preparation method according to claim 1, is characterized in that, described Chinese medicine composition is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
It is characterized in that, described preparation method step is as follows:
Bulbus Lilii, Radix Notoginseng, Endothelium Corneum Gigeriae Galli, Pollen Typhae, Rhizoma Corydalis, Rhizoma Anemones Altaicae Six-element medicated powder are broken into 80-200 order powder; Residue flavour of a drug decoct with water 2-4 time, each 0.5-3 hour, merge medicinal liquid and filter the extractum being concentrated into relative density 1.10-1.50; The alcohol heat reflux that medicinal residues after decoction add 30-80% extracts 1-2 time, each 0.5-2 hour, merges medicinal liquid and filters, reclaim ethanol, be concentrated into the extractum of relative density 1.10-1.50; Powder mixes with 2 kinds of extractum, obtains pharmaceutically active substance, through formulation method, is prepared into pharmaceutical preparations composition.
3. preparation method according to claim 1, is characterized in that, described Chinese medicine composition is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
It is characterized in that, described preparation method step is as follows:
Bulbus Lilii, Radix Notoginseng, Endothelium Corneum Gigeriae Galli, Pollen Typhae, Rhizoma Corydalis, Rhizoma Anemones Altaicae Six-element medicated powder are broken into 80-200 order powder; Residue flavour of a drug decoct with water 3 times, each 2 hours, merge medicinal liquid and filter the extractum being concentrated into relative density 1.10-1.50; The alcohol heat reflux that medicinal residues after decoction add 55% extracts 2 times, each 1 hour, merges medicinal liquid and filters, reclaim ethanol, be concentrated into the extractum of relative density 1.10-1.50; Powder mixes with 2 kinds of extractum, obtains pharmaceutically active substance, through formulation method, is prepared into pharmaceutical preparations composition.
4. preparation method according to claim 1, is characterized in that, described Chinese medicine composition is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
It is characterized in that, described preparation method step is as follows:
Bulbus Lilii, Radix Notoginseng, Endothelium Corneum Gigeriae Galli, Pollen Typhae, Rhizoma Corydalis, Rhizoma Anemones Altaicae Six-element medicated powder are broken into 80-200 order powder; Residue flavour of a drug decoct with water 3 times, each 2 hours, merge medicinal liquid and filter the extractum being concentrated into relative density 1.10-1.50; The alcohol heat reflux that medicinal residues after decoction add 55% extracts 2 times, each 1 hour, merges medicinal liquid and filters, reclaim ethanol, be concentrated into the extractum of relative density 1.10-1.50; Powder mixes with 2 kinds of extractum, obtains pharmaceutically active substance, and pill, drying make concentrated pill; Or powder mixes with extractum, granulates, capsule is made in drying or tablet.
5. preparation method according to claim 1, is characterized in that, described Chinese medicine composition is concentrated pill (containing concentrated watered pill, concentrated honeyed pill, condensed water honeyed pill).
6. preparation method according to claim 1, is characterized in that, described Chinese medicine composition is capsule.
7. preparation method according to claim 1, is characterized in that, described Chinese medicine composition is tablet.
8. preparation method according to claim 1, is characterized in that, described Chinese medicine composition is concentrated honeyed pill.
CN201510939830.5A 2015-12-16 2015-12-16 Preparation method and preparation of traditional Chinese medicinal composition for treating gastritis Withdrawn CN105456737A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510939830.5A CN105456737A (en) 2015-12-16 2015-12-16 Preparation method and preparation of traditional Chinese medicinal composition for treating gastritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510939830.5A CN105456737A (en) 2015-12-16 2015-12-16 Preparation method and preparation of traditional Chinese medicinal composition for treating gastritis

Publications (1)

Publication Number Publication Date
CN105456737A true CN105456737A (en) 2016-04-06

Family

ID=55595189

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510939830.5A Withdrawn CN105456737A (en) 2015-12-16 2015-12-16 Preparation method and preparation of traditional Chinese medicinal composition for treating gastritis

Country Status (1)

Country Link
CN (1) CN105456737A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1840091A (en) * 2005-04-02 2006-10-04 周宇 Novel medicine for treating atrophic gastritis and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1840091A (en) * 2005-04-02 2006-10-04 周宇 Novel medicine for treating atrophic gastritis and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张炳盛 等: "《中药药剂学》", 28 February 2013, 中国医药科技出版社 *
高立霞 等: "正交试验法优选摩罗片的提取工艺", 《泰山医学院学报》 *

Similar Documents

Publication Publication Date Title
CN101156906B (en) A pueraria root scutellaria and coptis medicinal composition
CN101569712A (en) Chinese traditional medicine composition for treating cold
CN105535533A (en) Traditional Chinese medicine composition for treatinggastritis
CN105477361B (en) A kind of Chinese medicine composition preparation method that treating gastritis and preparation
CN102920964A (en) Traditional Chinese medicine preparation for curing cough
CN102614260A (en) Medicine for treating gastric ulcer and duodenal ulcer and preparing method and application thereof
CN105477359B (en) A kind of Chinese medicine composition preparation method that treating gastritis and preparation
CN105477360A (en) Preparation method and preparation of traditional Chinese medicinal composition for treating gastritis
CN105456738A (en) Preparation method and preparation of traditional Chinese medicinal composition for treating gastritis
CN102641402B (en) Preparation method of traditional Chinese medicine compound preparation for treating nephritis
CN105497557A (en) Preparation method for traditional Chinese medicine composition for treating gastritis and preparation
CN105477362A (en) Preparation method of traditional Chinese medicinal composition for treating gastritis and preparation prepared by adopting preparation method
CN105477358A (en) Preparation method and preparation of traditional Chinese medicinal composition for treating gastritis
CN104547588B (en) A kind of preparation method of stomach health drop pills
CN105327149B (en) A kind of Chinese medicine composition preparation method that treating gastritis and preparation
CN105456737A (en) Preparation method and preparation of traditional Chinese medicinal composition for treating gastritis
CN105395889B (en) A kind of Chinese medicine composition preparation method that treating gastritis and preparation
CN105477364B (en) A kind of Chinese medicine composition preparation method that treating gastritis and preparation
CN105477363A (en) Preparation method of traditional Chinese medicinal composition for treating gastritis and preparation prepared by adopting preparation method
CN105381259B (en) A kind of Chinese medicine composition preparation method that treating gastritis and preparation
CN105381257A (en) Traditional Chinese medicine composition for treating gastritis and preparation thereof
CN105477375A (en) Traditional Chinese medicine composition for treating gastritis
CN105477366A (en) Preparation method of traditional Chinese medicinal composition for treating gastritis and preparation prepared by adopting preparation method
CN105477365A (en) Preparation method of traditional Chinese medicinal composition for treating gastritis and preparation prepared by adopting preparation method
CN105327150A (en) Preparing method for traditional Chinese medicine composition for treating gastritis and preparation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20160406